Glaxo says China bribery probe to hit performance | Bangkok Post: news

News > World

Glaxo says China bribery probe to hit performance

- +

GlaxoSmithKline expects its performance in China to take a hit from Beijing's probe into bribery allegedly carried out by senior staff, the British drugs firm said Wednesday, and described the matter as "shameful". 

A sign outside GlaxoSmithKline's offices in Shanghai, pictured on July 1, 2013. GlaxoSmithKline expects its financial performance in China to take a hit from Bejing's probe into bribery allegedly carried out by senior staff, the British pharmaceuticals company said on Wednesday.

"Clearly, we are likely to see some impact to our performance in China as a result of the current investigation, but it is too early to quantify the extent of this," GSK chief executive Andrew Witty said in a results statement.

This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.

0 people commented about the above

Readers are urged not to submit comments that may cause legal dispute including slanderous, vulgar or violent language, incorrectly spelt names, discuss moderation action, quotes with no source or anything deemed critical of the monarchy. More information in our terms of use.

Please use our forum for more candid, lengthy, conversational and open discussion between one another.

  • Latest
  • Oldest
  • Most replied to
  • Most liked
  • Most disliked

    Click here to view more comments